MNKD:NASDAQ
MannKind Corp
$3.34
arrow_upward
+1.52%(+0.050) 1D
$3.36
arrow_upward
+0.53% (+0.018)bedtimeAfter hours
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MNKD...
Open
$3.32
High
$3.39
Low
$3.17
Mkt. cap
1.07B
Avg. vol.
3.75M
Volume
8.85M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.10
Shares outstanding
321.54M
No. of employees
592
Open
$3.32
High
$3.39
Low
$3.17
Mkt. cap
1.07B
Avg. vol.
3.75M
Volume
8.85M
52-wk high
$6.51
52-wk low
$2.23
EPS
-$0.14
Beta
1.10
Shares outstanding
321.54M
No. of employees
592
News stories
From web sources and news partners
Investing.com Canada
·
10 hours ago
Form 144 MannKind Corporation For: 25 September By Investing.com
Stock Titan
·
10 hours ago
Shares valued at $128,478 are proposed for sale by MannKind (MNKD) director Steven Binder.
Profile
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann. Wikipedia
About MannKind Corp
CEOMichael Castagna
Employees592
FoundedFeb 1991
HeadquartersDanbury, Connecticut, United States
SectorBiotechnology
Websitemannkindcorp.com